Phathom Pharmaceuticals Inc (PHAT)
9.34
-0.11
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
9.32
-0.02
(-0.21%)
After-Hours: 20:00
Phathom Pharmaceuticals Profit Margin (Quarterly): -523.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -523.3% |
| June 30, 2024 | -1.25K% |
| Date | Value |
|---|---|
| March 31, 2024 | -4.33K% |
| December 31, 2023 | -11.67K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.67K%
Minimum
Dec 2023
-523.3%
Maximum
Sep 2024
-4.44K%
Average
-2.79K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -91.94% |
| Gross Profit Margin (Quarterly) | 85.59% |
| Operating Margin (Quarterly) | -433.0% |
| Return on Net Operating Assets | -2.36K% |